ArticleBreast cancer (Tokyo, Japan)2023

Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer.

Xin Qing et al.PubMed ↗Publisher ↗

No numbers read from the abstract.